Catechol-O-Methyltransferase gene polymorphism modifies the effect of coffee intake on incidence of acute coronary events

PLoS ONE

Volumn 1, Issue 1, 2006, Pages

  Happonen, Perti ^a   Voutilainen, Sari ^a   Tuomainen, Tomi Pekka ^a   Salonen, Jukka T ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b Oy Jurilab Ltd   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; CHOLESTEROL; ADRENALIN; CAFFEINE; CATECHOLAMINE; PRIMER DNA;

ACUTE CORONARY SYNDROME; ADULT; AGE DISTRIBUTION; ARTICLE; ASCORBIC ACID DEFICIENCY; BLOOD PRESSURE REGULATION; CHOLESTEROL BLOOD LEVEL; COFFEE; CONTROLLED STUDY; DIABETES MELLITUS; DNA EXTRACTION; ENZYME ACTIVITY; FAMILY HISTORY; FOOD INTAKE; GENE FUNCTION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PROTEIN METABOLISM; RISK ASSESSMENT; SMOKING; AGED; COHORT ANALYSIS; CORONARY ARTERY DISEASE; ENZYMOLOGY; FINLAND; GENETICS; HEART INFARCTION; METABOLISM; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PROSPECTIVE STUDY; RISK FACTOR; URINE;

ADULT; AGED; BASE SEQUENCE; CAFFEINE; CATECHOL O-METHYLTRANSFERASE; CATECHOLAMINES; COFFEE; COHORT STUDIES; CORONARY DISEASE; DNA PRIMERS; EPINEPHRINE; FINLAND; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 34447329428     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0000117     Document Type: Article

References (42)

1. Greenland S (1993) A meta-analysis of coffee, myocardial infarction, and coronary death. Epidemiology 4: 366-374.
2. Gyntelberg F, Hein HO, Suadicani P, Sørensen H (1995) Coffee consumption and risk of ischaemic heart disease - a settled issue? J Intern Med 237: 55-61.
3. Nawrot P, Jordan S, Eastwood J, Rotstein J, Hugenholtz A, et al. (2003) Effects of caffeine on human health. Food Addit Contam 20: 1-30.
4. Boekschoten MV, Engberink MF, Katan MB, Schouten EG (2003) Reproducibility of the serum lipid response to coffee oil in healthy volunteers. Nutr J 2: 8.
5. Svilaas A, Sakhi AK, Andersen LF, Svilaas T, Ström EC, et al. (2004) Intakes of antioxidants in coffee, wine, and vegetables are correlated with plasma carotenoids in humans. J Nutr 134: 562-567.
6. Corti R, Binggeli C, Sudano I, Spieker L, Hänseler E, et al. (2002) Coffee acutely increases sympathetic nerve activity and blood pressure independently of caffeine content: role of habitual versus nonhabitual drinking. Circulation 106: 2935-2940.
7. Happonen P, Voutilainen S, Salonen JT (2004) Coffee drinking is dose-dependently related to the risk of acute coronary events in middle-aged men. J Nutr 134: 2381-2386.
8. Woodward M, Tunstall-Pedoe H (1999) Coffee and tea consumption in the Scottish Heart Health Study follow up: conflicting relations with coronary risk factors, coronary disease, and all cause mortality. J Epidemiol Community Health 53: 481-487.
9. Panagiotakos DB, Pitsavos C, Chrysohoou C, Kokkinos P, Toutouzas P, et al. (2003) The J-shaped effect of coffee consumption on the risk of developing acute coronary syndromes: the CARDIO2000 case-control study. J Nutr 133: 3228-3232.
10. Robertson D, Frölich JC, Carr RK, Watson JT, Hollifield JW, et al. (1978) Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med 298: 181-186.
11. Robertson D, Wade D, Workman R, Woosley RL, Oates JA (1981) Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest 67: 1111-1117.
12. Lane JD, Adcock RA, Williams RB, Kuhn CM (1990) Caffeine effects on cardiovascular and neuroendocrine responses to acute psychosocial stress and their relationship to level of habitual caffeine consumption. Psychosom Med 52: 320-336.
13. Whitsett TL, Manion CV, Christensen HD (1984) Cardiovascular effects of coffee and caffeine. Am J Cardiol 53: 918-922.
14. Pincomb GA, Lovallo WR, Passey RB, Wilson MF (1988) Effect of behavior state on caffeine's ability to alter blood pressure. Am J Cardiol 61: 798-802.
15. Salonen JT (1988) Is there a continuing need for longitudinal epidemiologic research? The Kuopio Ischaemic Heart Disease Risk Factor Study. Ann Clin Res 20: 46-50.
16. Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppänen R, et al. (1992) High stored iron levels are associated with excess risk of myocardial infarction in Eastern Finnish men. Circulation. 86: 803-811.
17. Ihanainen M, Salonen R, Seppaänen R, Salonen JT (1989) Nutrition data collection in the Kuopio Ischaemic Heart Disease Risk Factor Study: Nutrient intake of middle-aged Eastern Finnish men. Nutr Res 9: 597-604.
18. Lakka TA, Venaälaäinen JM, Rauramaa R, Salonen R, Tuomilehto J, et al. (1994) Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction. N Engl J Med 330: 1549-1554.
19. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, et al. (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288: 2709-2716.
20. Nyyssönen K, Parviainen MT, Salonen R, Tuomilehto J, Salonen JT (1997) Vitamin C deficiency and risk of myocardial infarction: prospective population study of men from eastern Finland. BMJ 314: 634-638.
21. Salonen JT, Salonen R, Ihanainen M, Parviainen M, Seppanen R, et al. (1988) Blood pressure, dietary fats, and antioxidants. Am J Clin Nutr 48: 1226-1232.
22. Tuomilehto J, Arstila M, Kaarsalo E, Kankaanpaää J, Ketonen M, et al. (1992) Acute myocardial infarction (AMI) in Finland - baseline data from the FINMONICA AMI register in 1983-1985. Eur Heart J 13: 577-587.
23. Wilson PWF, Garrison RJ, Kannel WB, McGee DL, Castelli WP (1989) Is coffee consumption a contributor to cardiovascular disease? Insights from the Framingham study. Arch Intern Med 149: 1169-1172.
24. Grobbee DE, Rimm EB, Giovannucci E, Colditz G, Stampfer M, et al. (1990) Coffee, caffeine, and cardiovascular disease in men. N Engl J Med 323: 1026-1032.
25. Willett WC, Stampfer MJ, Manson JE, Colditz GA, Rosner BA, et al. (1996) Coffee consumption and coronary heart disease in women. A ten-year follow-up. JAMA 275: 458-462.
26. Rosenberg L, Palmer JR, Kelly JP, Kaufman DW, Shapiro S (1988) Coffee drinking and nonfatal myocardial infarction in men under 55 years of age. Am J Epidemiol 128: 570-578.
27. LaCroix AZ, Mead LA, Liang KY, Thomas CB, Pearson TA (1986) Coffee consumption and the incidence of coronary heart disease. N Engl J Med 315: 977-982.
28. Kleemola P, Jousilahti P, Pietinen P, Vartiainen E, Tuomilehto J (2000) Coffee consumption and the risk of coronary heart disease and death. Arch Intern Med 160: 3393-3400.
29. Tavani A, Bertuzzi M, Negri E, Sorbara L, La Vecchia C (2001) Alcohol, smoking, coffee and risk of non-fatal acute myocardial infarction in Italy. Eur J Epidemiol 17: 1131-1137.
30. Hammar N, Andersson T, Alfredsson L, Reuterwall C, Nilsson T, et al. (2003) Association of boiled and filtered coffee with incidence of first nonfatal myocardial infarction: the SHEEP and the VHEEP study. J Intern Med 253: 653-659.
31. Thelle DS (1995) Coffee, tea and coronary heart disease. Curr Opin Lipidol 6: 25-27.
32. Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H (2006) Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA 295: 1135-1141.
33. Smits P, Pieters G, Thien T (1986) The role of epinephrine in the circulatory effects of coffee. Clin Pharmacol Ther 40: 431-437.
34. Gidron Y, Gilutz H, Berger R, Huleihel M (2002) Molecular and cellular interface between behavior and acute coronary syndromes. Cardiovasc Res 56: 15-21.
35. Madsen SN, Fog-Moller F, Christiansen C, Vester-Andersen T, Engquist A (1978) Cyclic AMP, adrenaline and noradrenaline in plasma during surgery. Br J Surg 65: 191-193.
36. Stevens RD, Burri H, Tramer MR (2003) Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review. Anesth Analg 97: 623-633.
37. Eisenhofer G, Huynh TT, Hiroi M, Pacak K (2001) Understanding catecholamine metabolism as a guide to the biochemical diagnosis of pheochromocytoma. Rev Endocr Metab Disord 2: 297-311.
38. Syvänen AC, Tilgmann C, Rinne J, Ulmanen I (1997) Genetic polymorphism of catechol-O-methyltransferase (COMT): correlation of genotype with individual variation of S-COMT activity and comparison of the allele frequencies in the normal population and parkinsonian patients in Finland. Pharmacogenetics 7: 65-71.
39. Kumada Y, Naganawa H, Iinuma H, Matsuzaki M, Takeuchi T (1976) Dehydrodicaffeic acid dilactone, an inhibitor of catechol-O-methyl transferase. J Antibiot (Tokyo) 29: 882-889.
40. Saboury AA, Divsalar A, Ataie G, Amanlou M, Moosavi-Movahedi AA, et al. (2003) Inhibition study of adenosine deaminase by caffeine using spectroscopy and isothermal titration calorimetry. Acta Biochim Pol 50: 849-855.
41. Zhu BT (2002) On the mechanism of homocysteine pathophysiology and pathogenesis: a unifying hypothesis. Histol Histopathol 17: 1283-1291.
42. Brandin L, Bergström G, Manhem K, Gustafsson H (2003) Oestrogen modulates vascular adrenergic reactivity of the spontaneously hypertensive rat. J Hypertens 21: 1695-1702.